In particular, in the aged heart, high-dose FF may exacerbate myocardial fibrosis while enhancing the expression of PGC-1α and phospho-AMPK, and, more significantly than in the young heart, stimulate intracellular lipid accumulation and cardiac hypertrophy markers. The gene discussed is PPARGC1A; the disease is Myocardial fibrosis.